The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Exercise-based Interventions for Nonalcoholic Fatty Liver Disease: A Meta-analysis and Meta-regression
Open accessAbstract
BACKGROUND & AIMS The burden of nonalcoholic fatty liver disease (NAFLD) is increasing worldwide. We performed a meta-analysis to determine the effectiveness of exercise-based lifestyle interventions on liver-specific end points in populations with NAFLD and underlying metabolic disorders such as obesity, type 2 diabetes, or metabolic syndrome. METHODS We searched PubMed-MEDLINE, Embase, and the Cochrane Central register through October 21, 2015 for randomized trials of exercise-based lifestyle interventions on end points such as intrahepatic lipid content and blood levels of alanine and aspartate aminotransferases. Effect sizes are reported as standardized mean difference and weighted mean difference values. To investigate heterogeneity, we performed sensitivity and meta-regression analyses. Results were reported according to the PRISMA statement. RESULTS We analyzed data from 28 trials. Physical activity, independently from diet change, was associated with a significant reduction in intrahepatic lipid content (standardized mean difference, -0.69; 95% confidence interval [CI], -0.90 to -0.48) and with reductions in alanine aminotransferase (weighted mean difference, -3.30 IU/L; 95% CI, 5.57 to -1.04) and aspartate aminotransferase (weighted mean difference, -4.85 IU/L; 95% CI, -8.68 to -1.02). By meta-regression, we found individuals with increasing body mass index to be increasingly more likely to benefit from the intervention (beta coefficient = -0.10; P = .037). We recorded no effect modification by variables related to the intensity of the intervention. CONCLUSIONS In a meta-analysis of randomized trials, we found strong evidence that physical activity reduces intrahepatic lipid content and markers of hepatocellular injury in patients with NAFLD. This effect correlated with baseline body mass index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239
Jaeschke, R., Singer, J., & Guyatt, G. H. (1989) · Controlled Clinical Trials · doi:10.1016/0197-2456(89)90005-6 · Cited by 4,982
Norman, G. R., Sloan, J. A., & Wyrwich, K. W. (2003) · Medical Care · doi:10.1097/01.mlr.0000062554.74615.4c · Cited by 4,700
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2008) · Nature Genetics · doi:10.1038/ng.257 · Cited by 3,416
Johnson, N. A., Sachinwalla, T., Walton, D. W., Smith, K., Armstrong, A., Thompson, M. W., & George, J. (2009) · Hepatology · doi:10.1002/hep.23129 · Cited by 631
Hupin, D., Roche, F., Gremeaux, V., Chatard, J.-C., Oriol, M., Gaspoz, J.-M., Barthélémy, J.-C., & Edouard, P. (2015) · British Journal of Sports Medicine · doi:10.1136/bjsports-2014-094306 · Cited by 565
Noureddin, M., Lam, J., Peterson, M. R., Middleton, M., Hamilton, G., Le, T.-A., Bettencourt, R., Changchien, C., Brenner, D. A., Sirlin, C., et al. (2013) · Hepatology · doi:10.1002/hep.26455 · Cited by 550
Hallsworth, K., Fattakhova, G., Hollingsworth, K. G., Thoma, C., Moore, S., Taylor, R., Day, C. P., & Trenell, M. I. (2011) · Gut · doi:10.1136/gut.2011.242073 · Cited by 529
Harrison, S. A., Fecht, W., Brunt, E. M., & Neuschwander‐Tetri, B. A. (2009) · Hepatology · doi:10.1002/hep.22575 · Cited by 470
Lazo, M., Solga, S. F., Horska, A., Bonekamp, S., Diehl, A. M., Brancati, F. L., Wagenknecht, L. E., Pi-Sunyer, F. X., Kahn, S. E., Clark, J. M., et al. (2010) · Diabetes Care · doi:10.2337/dc10-0856 · Cited by 367
Speliotes, E. K., Butler, J. L., Palmer, C. D., Voight, B. F., & Hirschhorn, J. N. (2010) · Hepatology · doi:10.1002/hep.23768 · Cited by 362
Bacchi, E., Negri, C., Targher, G., Faccioli, N., Lanza, M., Zoppini, G., Zanolin, E., Schena, F., Bonora, E., & Moghetti, P. (2013) · Hepatology · doi:10.1002/hep.26393 · Cited by 350
Effect of aerobic exercise training dose on liver fat and visceral adiposity
Keating, S. E., Hackett, D. A., Parker, H. M., O’Connor, H. T., Gerofi, J. A., Sainsbury, A., Baker, M. K., Chuter, V. H., Caterson, I. D., George, J., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.022 · Cited by 313
Slentz, C. A., Bateman, L. A., Willis, L. H., Shields, A. T., Tanner, C. J., Piner, L. W., Hawk, V. H., Muehlbauer, M. J., Samsa, G. P., Nelson, R. C., et al. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00291.2011 · Cited by 235
Shah, K., Stufflebam, A., Hilton, T. N., Sinacore, D. R., Klein, S., & Villareal, D. T. (2009) · Obesity · doi:10.1038/oby.2009.126 · Cited by 194
Patel, N. S., Doycheva, I., Peterson, M. R., Hooker, J., Kisselva, T., Schnabl, B., Seki, E., Sirlin, C. B., & Loomba, R. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.08.039 · Cited by 173
Thompson, D., Markovitch, D., Betts, J. A., Mazzatti, D., Turner, J., & Tyrrell, R. M. (2010) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00822.2009 · Cited by 123
Research works printed but not linked: 40
- Michelotti, 2013, NAFLD, NASH and liver cancer, Nat Rev Gastroenterol Hepatol, 10, 656, 10.1038/nrgastro.2013.183 · DOI · Paper page
- Blachier, 2013, The burden of liver disease in Europe: a review of available epidemiological data, J Hepatol, 58, 593, 10.1016/j.jhep.2012.12.005 · DOI · Paper page
- Lazo, 2013, Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994, Am J Epidemiol, 178, 38, 10.1093/aje/kws448 · DOI · Paper page
- Zelber-Sagi, 2006, Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures, Liver Int, 26, 856, 10.1111/j.1478-3231.2006.01311.x · DOI · Paper page
- Jimba, 2005, Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults, Diabetic Med, 22, 1141, 10.1111/j.1464-5491.2005.01582.x · DOI · Paper page
- Fan, 2013, Epidemiology of alcoholic and nonalcoholic fatty liver disease in China, J Gastrotenterol Hepatol, 28, 11, 10.1111/jgh.12036 · DOI · Paper page
- Das, 2010, Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease, Hepatology, 51, 1593, 10.1002/hep.23567 · DOI · Paper page
- Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, PLoS Med, 6, e1000097, 10.1371/journal.pmed.1000097 · DOI · Paper page
- Antuna-Puente, 2011, How can we measure insulin sensitivity/resistance?, Diabetes Metab, 37, 179, 10.1016/j.diabet.2011.01.002 · DOI · Paper page
- Egger, 1997, Bias in meta-analysis detected by a simple, graphical test, Br Med J, 315, 629, 10.1136/bmj.315.7109.629 · DOI · Paper page
- Al-Jiffri, 2013, Weight reduction improves markers of hepatic function and insulin resistance in type-2 diabetic patients with non-alcoholic fatty liver, Afr Health Sci, 13, 667
- de Piano, 2012, Long-term effects of aerobic plus resistance training on the adipokines and neuropeptides in nonalcoholic fatty liver disease obese adolescents, Eur J Gastroenterol Hepatol, 24, 1313
- Eckard, 2013, Prospective histopathologic evaluation of lifestyle modification in nonalcoholic fatty liver disease: a randomized trial, Therap Adv Gastroenterol, 6, 249, 10.1177/1756283X13484078 · DOI
- Finucane, 2010, The effects of aerobic exercise on metabolic risk, insulin sensitivity and intrahepatic lipid in healthy older people from the Hertfordshire Cohort Study: a randomised controlled trial, Diabetologia, 53, 624, 10.1007/s00125-009-1641-z · DOI
- Larson-Meyer, 2008, Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function, Obesity, 16, 1355, 10.1038/oby.2008.201 · DOI · Paper page
- Lee, 2012, Effects of aerobic versus resistance exercise without caloric restriction on abdominal fat, intrahepatic lipid, and insulin sensitivity in obese adolescent boys: a randomized, controlled trial, Diabetes, 61, 2787, 10.2337/db12-0214 · DOI · Paper page
- Lee, 2013, Aerobic exercise but not resistance exercise reduces intrahepatic lipid content and visceral fat and improves insulin sensitivity in obese adolescent girls: a randomized controlled trial, Am J Physiol Endocrinol Metab, 305, E1222, 10.1152/ajpendo.00285.2013 · DOI · Paper page
- Levinger, 2009, Inflammation, hepatic enzymes and resistance training in individuals with metabolic risk factors, Diabetic Med, 26, 220, 10.1111/j.1464-5491.2009.02679.x · DOI
- Promrat, 2010, Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis, Hepatology, 51, 121, 10.1002/hep.23276 · DOI · Paper page
- Pugh, 2013, Exercise training improves cutaneous microvascular function in nonalcoholic fatty liver disease, Am J Physiol Endocrinol Metab, 305, E50, 10.1152/ajpendo.00055.2013 · DOI
- Savoye, 2014, Reversal of early abnormalities in glucose metabolism in obese youth: results of an intensive lifestyle randomized controlled trial, Diabetes Care, 37, 317, 10.2337/dc13-1571 · DOI
- Shojaee-Moradie, 2007, Exercise training reduces fatty acid availability and improves the insulin sensitivity of glucose metabolism, Diabetologia, 50, 404, 10.1007/s00125-006-0498-7 · DOI · Paper page
- St George, 2009, Independent effects of physical activity in patients with nonalcoholic fatty liver disease, Hepatology, 50, 68, 10.1002/hep.22940 · DOI · Paper page
- Sullivan, 2012, Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease, Hepatology, 55, 1738, 10.1002/hep.25548 · DOI · Paper page
- Valizadeh, 2011, The effect of eight weeks elected aerobic exercise on the levels of (AST, ALT) enzymes of men patients with fat liver, Proced Soc Behav Sci, 3362, 10.1016/j.sbspro.2011.04.300 · DOI
- Wang, 2008, Effect of lifestyle intervention on non-alcoholic fatty liver disease in Chinese obese children, World J Gastroenterol, 14, 1598, 10.3748/wjg.14.1598 · DOI
- Wong, 2013, Community-based lifestyle modification programme for non-alcoholic fatty liver disease: a randomized controlled trial, J Hepatol, 59, 536, 10.1016/j.jhep.2013.04.013 · DOI · Paper page
- Zelber-Sagi, 2014, The effect of resistance training on non-alcoholic fatty liver disease (NAFLD): a randomized clinical trial, World J Gastroenterol, 20, 4382, 10.3748/wjg.v20.i15.4382 · DOI · Paper page
- Straznicky, 2012, The effects of dietary weight loss with or without exercise training on liver enzymes in obese metabolic syndrome subjects, Diabetes Obes Metab, 14, 139, 10.1111/j.1463-1326.2011.01497.x · DOI
- Tamura, 2005, Effects of diet and exercise on muscle and liver intracellular lipid contents and insulin sensitivity in type 2 diabetic patients, J Clin Endocrinol Metab, 90, 3191, 10.1210/jc.2004-1959 · DOI · Paper page
- Fedewa, 2014, Exercise and insulin resistance in youth: a meta-analysis, Pediatrics, 133, e163, 10.1542/peds.2013-2718 · DOI · Paper page
- Faraone, 2008, Interpreting estimates of treatment effects: implications for managed care, Pharma Therap, 33, 700
- Schwimmer, 2015, Magnetic resonance imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver disease, Hepatology, 61, 1887, 10.1002/hep.27666 · DOI · Paper page
- Vos, 2015, Is it time to advance pediatric NAFLD diagnosis to the magnetic resonance imaging era?, Hepatology, 61, 1779, 10.1002/hep.27808 · doi:10.1002/hep.27808
- Berardis, 2014, Pediatric non-alcoholic fatty liver disease: an increasing public health issue, Eur J Pediatr, 173, 131, 10.1007/s00431-013-2157-6 · DOI
- Marzuillo, 2015, Controversy in the diagnosis of pediatric non-alcoholic fatty liver disease, World J Gastroenterol, 21, 6444, 10.3748/wjg.v21.i21.6444 · DOI
- Wardle, 2006, Development of adiposity in adolescence: five year longitudinal study of an ethnically and socioeconomically diverse sample of young people in Britain, Br Med J, 332, 1130, 10.1136/bmj.38807.594792.AE · DOI · Paper page
- Oh, 2015, Moderate to vigorous physical activity volume is an important factor for managing nonalcoholic fatty liver disease: a retrospective study, Hepatology, 61, 1205, 10.1002/hep.27544 · DOI · Paper page
- Unick, 2013, The long-term effectiveness of a lifestyle intervention in severely obese individuals, Am J Med, 126, 236, 10.1016/j.amjmed.2012.10.010 · DOI
- Kistler, 2011, Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease, Am J Gastroenterol, 106, 460, 10.1038/ajg.2010.488 · DOI · Paper page
Cited by
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
Polyzos, S. A., Kountouras, J., & Mantzoros, C. S. (2019) · Metabolism · doi:10.1016/j.metabol.2018.11.014 · Cited by 1,211
Cusi, K., Isaacs, S., Barb, D., Basu, R., Caprio, S., Garvey, W. T., Kashyap, S., Mechanick, J. I., Mouzaki, M., Nadolsky, K., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.03.010 · Cited by 1,021
Eslam, M., Sarin, S. K., Wong, V. W.-S., Fan, J.-G., Kawaguchi, T., Ahn, S. H., Zheng, M.-H., Shiha, G., Yilmaz, Y., Gani, R., et al. (2020) · Hepatology International · doi:10.1007/s12072-020-10094-2 · Cited by 833
Ballestri, S., Nascimbeni, F., Baldelli, E., Marrazzo, A., Romagnoli, D., & Lonardo, A. (2017) · Advances in Therapy · doi:10.1007/s12325-017-0556-1 · Cited by 545
Non-alcoholic fatty liver disease
Neuschwander-Tetri, B. A. (2017) · BMC Medicine · doi:10.1186/s12916-017-0806-8 · Cited by 451
Metadata
- Authors
- Orci, L. A., Gariani, K., Oldani, G., Delaune, V., Morel, P., & Toso, C.
- Venue
- Clinical Gastroenterology and Hepatology
- Publisher
- Elsevier BV
- Published
- 2016-10
- Volume
- 14
- Issue
- 10
- Pages
- 1398-1411
- ISSN
- 1542-3565 (ISSN-L)
- OpenAlex
- W2346495725
- Cited by
- 209
- References
- 19
- FWCI
- 3.21
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.